Florida Governor Ron DeSantis and State Health Officials Directly Call the White House and FDA Liars During Monoclonal Treatment Fight

All Global Research articles can be read in 51 languages by activating the “Translate Website” drop down menu on the top banner of our home page (Desktop version).

To receive Global Research’s Daily Newsletter (selected articles), click here.

Visit and follow us on Instagram at @globalresearch_crg.

***

Keep an eye on this story folks; there’s something else here.

The FDA decision to block COVID-19 treatment options is very sketchy, and I sense that Florida Governor Ron DeSantis knows the science will not support the Biden administration.  This story -when exposed- has the potential to bring down the Biden administration, big time… DeSantis senses it.

Earlier today, Florida Governor Ron DeSantis held a roundtable press conference with physicians, clinicians and other health officials in Florida to denounce the Biden FDA decision to revoke monoclonal antibody treatments as a therapeutic option.  The FDA action was not only done without communication, but the decision was also made without study and without any input from the treatment side of the COVID-19 dynamic.

Here’s a brief segment of the DeSantis statement:

The full presser is below and is well worth watching to listen to the doctors who refute the FDA claim that monoclonal treatments do not assist patients with Omicron variant.  Doctors have treated Omicron patients successfully with the monoclonal antibody treatments. The actual doctors who are treating the patients refute the FDA directly.

The input from Dr. Dwight Reynolds is very revealing. Something is very odd around this story.

*

Note to readers: Please click the share buttons above or below. Follow us on Instagram, @crg_globalresearch. Forward this article to your email lists. Crosspost on your blog site, internet forums. etc.

Featured image is from TLR


Articles by: Sundance

Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]

www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.

For media inquiries: [email protected]